The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And this company actually Griffles had also run a clinical study that was blinded placebo controlled in patients with Alzheimer's disease where they first removed their plasma this is called therapeutic plasma exchange and then infused them back with um a major blood component this albamine which also contains other factors and they saw for clear significant benefits and this was in 500 patients.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.